These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 31926846)
1. Response to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study. Poisson K; Wong M; Lee C; Cilio MR Eur J Paediatr Neurol; 2020 Mar; 25():77-81. PubMed ID: 31926846 [TBL] [Abstract][Full Text] [Related]
2. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611 [TBL] [Abstract][Full Text] [Related]
3. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy. Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures. Kuchenbuch M; Benquet P; Kaminska A; Roubertie A; Carme E; de Saint Martin A; Hirsch E; Dubois F; Laroche C; Barcia G; Chemaly N; Milh M; Villeneuve N; Sauleau P; Modolo J; Wendling F; Nabbout R Epilepsia; 2019 Jan; 60(1):20-32. PubMed ID: 30525185 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review. Gras M; Bearden D; West J; Nabbout R Epilepsia Open; 2024 Aug; 9(4):1176-1191. PubMed ID: 39093319 [TBL] [Abstract][Full Text] [Related]
6. Cannabis for the Treatment of Epilepsy: an Update. Gaston TE; Szaflarski JP Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563 [TBL] [Abstract][Full Text] [Related]
7. KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report. Takase C; Shirai K; Matsumura Y; Watanabe T; Watanabe A; Hirasawa-Inoue A; Mizuguchi T; Matsumoto N; Sugai K; Hayashi M Brain Dev; 2020 Sep; 42(8):607-611. PubMed ID: 32505479 [TBL] [Abstract][Full Text] [Related]
8. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312 [TBL] [Abstract][Full Text] [Related]
9. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases. Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590 [TBL] [Abstract][Full Text] [Related]
10. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP. Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509 [TBL] [Abstract][Full Text] [Related]
11. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511 [TBL] [Abstract][Full Text] [Related]
12. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide. Datta AN; Michoulas A; Guella I; ; Demos M J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268 [No Abstract] [Full Text] [Related]
13. [Early infantile epileptic encephalopathy type 14: three cases of epilepsy in infancy with migrating focal seizures due to KCNT1 mutations]. Kholin AA; Zavadenko NN; Fedonyuk ID; Antonets AV; Mukhin KY; Malov AG; Vshivkov MI; Anisimov GV; Il'ina ES Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7. Vyp. 2):74-82. PubMed ID: 31532594 [TBL] [Abstract][Full Text] [Related]
14. The severe epilepsy syndromes of infancy: A population-based study. Howell KB; Freeman JL; Mackay MT; Fahey MC; Archer J; Berkovic SF; Chan E; Dabscheck G; Eggers S; Hayman M; Holberton J; Hunt RW; Jacobs SE; Kornberg AJ; Leventer RJ; Mandelstam S; McMahon JM; Mefford HC; Panetta J; Riseley J; Rodriguez-Casero V; Ryan MM; Schneider AL; Smith LJ; Stark Z; Wong F; Yiu EM; Scheffer IE; Harvey AS Epilepsia; 2021 Feb; 62(2):358-370. PubMed ID: 33475165 [TBL] [Abstract][Full Text] [Related]
15. Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Devinsky O; Verducci C; Thiele EA; Laux LC; Patel AD; Filloux F; Szaflarski JP; Wilfong A; Clark GD; Park YD; Seltzer LE; Bebin EM; Flamini R; Wechsler RT; Friedman D Epilepsy Behav; 2018 Sep; 86():131-137. PubMed ID: 30006259 [TBL] [Abstract][Full Text] [Related]
16. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures. Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692 [TBL] [Abstract][Full Text] [Related]
17. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy. Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531 [TBL] [Abstract][Full Text] [Related]
18. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy. Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761 [TBL] [Abstract][Full Text] [Related]
19. A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant. El Halabi T; Dirani M; Hotait M; Nasreddine W; Beydoun A Epilepsia Open; 2021 Mar; 6(1):73-78. PubMed ID: 33681650 [TBL] [Abstract][Full Text] [Related]
20. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. Saade D; Joshi C Pediatr Neurol; 2015 May; 52(5):544-7. PubMed ID: 25882081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]